We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$206M
RCM
2
RA Capital Management
Massachusetts
$37.2M -$11.5M -745,843 -23%
BlackRock
3
BlackRock
New York
$21.6M +$4.81M +312,364 +28%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$20.8M +$13.9M +900,000 +181%
Citadel Advisors
5
Citadel Advisors
Florida
$17.5M +$44.1K +2,866 +0.2%
BC
6
Boxer Capital
California
$16.7M
APM
7
Avidity Partners Management
Texas
$15.3M +$15.8M +1,028,800 New
Fidelity Investments
8
Fidelity Investments
Massachusetts
$11.1M -$718K -46,600 -6%
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.9M +$5.61M +364,402 +100%
AG
10
Artal Group
Luxembourg
$5.51M +$2.62M +170,000 +85%
Morgan Stanley
11
Morgan Stanley
New York
$5.5M +$4.5M +292,096 +380%
EC
12
EcoR1 Capital
California
$5.47M -$29M -1,881,088 -84%
WP
13
Woodline Partners
California
$4.9M +$1.2M +77,603 +31%
CI
14
Clal Insurance
Israel
$4.35M
Bank of America
15
Bank of America
North Carolina
$3.81M -$49.2K -3,194 -1%
State Street
16
State Street
Massachusetts
$3.65M +$548K +35,594 +17%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$2.94M -$426K -27,686 -12%
OFM
18
Omega Fund Management
Massachusetts
$2.79M -$1.31M -85,269 -31%
Federated Hermes
19
Federated Hermes
Pennsylvania
$2.65M +$2.73M +177,547 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.44M +$136K +8,856 +6%
Northern Trust
21
Northern Trust
Illinois
$2.04M -$315K -20,477 -13%
QF
22
QVT Financial
New York
$1.99M
Millennium Management
23
Millennium Management
New York
$1.9M +$479K +31,124 +32%
DCM
24
DAFNA Capital Management
California
$1.12M
UBS Group
25
UBS Group
Switzerland
$1.09M -$25.4K -1,652 -2%